One attractive strategy is to target key regulators of the intrinsic apoptosis pathway; this includes targeting the anti-apoptotic proteins (BCL2, BCLXL, and MCL1) with BH3 mimetics to breach the apoptotic threshold and drive PCa cell death.5 This evidence concerns the gene BCL2 and posterior cortical atrophy.